Low priced incentive drugs amounting to 620 billion won.

The current provision describes that the pharmacist would be paid with about 30% balance from the expensive branded drugs when substituting for the incentive and cheaper drugs. The total value of such incentive and low priced drugs estimated to 620 billion won as of the end of 2004.

Accordingly, given such a favorable circumstance, the pharmacist should positively take part in the substitut...